Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 63
Filter
2.
Equine Vet J ; 42(8): 746-57, 2010 Nov.
Article in English | MEDLINE | ID: mdl-21039806

ABSTRACT

Penile and preputial tumours are not uncommon in the horse, but can cause discomfort and lead to serious complications. Several types of tumour of the male external genitalia have been described. The most common type is the squamous cell carcinoma (SCC), which is found mainly in older horses. Reports of a breed predilection for penile tumour formation are equivocal, but castration, coat colour, poor hygiene and various infectious agents have all been suggested to predispose to the development of some types of tumour (e.g. SCC, papilloma and melanoma). Careful assessment of the primary tumour is an important first step in the design of an optimal treatment protocol. Invasiveness, differentiation grade, tumour size and presence of metastases are all relevant to the decision to pursue additional diagnostic procedures or specific treatment options. To date, no standard protocol has been reported for the approach to penile tumours in the horse and treatments range from minimally invasive therapies (e.g. topical use of 5-fluorouracil) to radical surgical interventions (e.g. en bloc penile and preputial resection with penile retroversion). Completeness of removal of the neoplasm and therefore risk of recurrence is highly dependent on the type of therapy chosen. However, the size and histopathological features of the primary tumour are also important factors with respect to the likelihood of recurrence. This review describes the most common penile and preputial neoplasms in the horse, and outlines a standard protocol aimed at arriving at a specific diagnosis and tailoring the therapeutic approach accordingly.


Subject(s)
Genital Neoplasms, Male/veterinary , Horse Diseases/therapy , Animals , Genital Neoplasms, Male/therapy , Horses , Male
3.
Equine Vet J ; 41(9): 872-6, 2009 Dec.
Article in English | MEDLINE | ID: mdl-20383984

ABSTRACT

REASONS FOR PERFORMING STUDY: Infundibular changes are frequently encountered computed tomographic studies of the equine maxillary cheek teeth but the possible importance of this finding is not known. Infundibular caries is a possible cause for pulpitis and apical infection in some horses. OBJECTIVES: To study the relationship between the 2 pathologies and the frequency of changes. METHODS: The maxillary cheek teeth 108-208, 109-209 and 110-210 of 25 horses were evaluated using computed tomography and both the prevalence of infundibular and apical infection changes as the possible link with apical infection evaluated statistically. RESULTS: The prevalence of infundibular changes was high in both normal and diseased teeth. Both apical infection and the occurrence of infundibular changes were more prevalent in 109-209 and 110-210. In spite of this, the 2 processes could not be linked to one another. No differences were noted between the left and right sides. CONCLUSIONS: A direct relationship between the 2 processes was not established statistically and other underlying causes for the high occurrence of both apical infection and infundibular changes in diseased and normal 108-208, 109-209 and 110-210 are considered.


Subject(s)
Horse Diseases/diagnostic imaging , Molar/diagnostic imaging , Periapical Abscess/veterinary , Tomography, X-Ray Computed/veterinary , Animals , Dental Caries/veterinary , Horses , Periapical Abscess/diagnostic imaging
5.
Equine Vet J ; 40(6): 528-32, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18487101

ABSTRACT

REASONS FOR PERFORMING STUDY: Preputial and penile tumours are more common in horses than in other domestic animals, but no large surveys of male horses with tumours of the external genitalia are available. OBJECTIVE: To present a retrospective analysis of male horses with neoplasms of the external genitalia. METHODS: The penile and preputial tumours of 114 horses were evaluated. Data recorded included age, gelding or stallion and breed; type and site of lesion; involvement of regional lymph nodes; histopathology (including grading of squamous cell carcinoma); and results of radiographic examination of the thorax. RESULTS: Mean age of horses was 19.5 years with no apparent breed predilection. Common presenting clinical signs were irregularities (e.g. the presence of a mass and/or ulceration) on the integument of the penis and prepuce, and purulent or sanguineous discharge from preputial orifice. Squamous cell carcinoma (SCC) was the most prevalent neoplasm followed by papillomas and melanomas. A basal cell carcinoma, neurofibrosarcoma, adenocarcinoma or fibrosarcoma were each found on single horses. Squamous cell carcinomas with poor differentiation had a higher tendency to metastasise than did more differentiated tumours. CONCLUSIONS: Squamous cell carcinoma is the most common urogenital tumour of the male horse and occurs primarily in old horses. Horses with poorly differentiated SCCs tend to have a higher incidence of regional metastases. Pathology of lymph nodes, even when not palpably enlarged, is a valuable diagnostic exercise. Radiology of the thorax to detect lung metastases is of little value.


Subject(s)
Carcinoma, Squamous Cell/veterinary , Horse Diseases/pathology , Penile Neoplasms/veterinary , Age Factors , Animals , Breeding , Carcinoma, Squamous Cell/epidemiology , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/surgery , Horse Diseases/epidemiology , Horse Diseases/surgery , Horses , Lymph Nodes/pathology , Lymph Nodes/surgery , Lymphatic Metastasis/diagnosis , Male , Neoplasm Metastasis/diagnosis , Neoplasm Staging/veterinary , Orchiectomy/veterinary , Papilloma/epidemiology , Papilloma/pathology , Papilloma/surgery , Papilloma/veterinary , Pedigree , Penile Neoplasms/epidemiology , Penile Neoplasms/pathology , Penile Neoplasms/surgery , Penis/pathology , Penis/surgery , Retrospective Studies , Urethra/pathology , Urethra/surgery
6.
Equine Vet J ; 40(6): 533-7, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18487102

ABSTRACT

REASONS FOR PERFORMING STUDY: The most common penile and preputial neoplasm in the horse is the squamous cell carcinoma (SCC), but no large surveys of treatment and effects of the grade of the tumour, based on the degree of differentiation, on outcome of affected horses are available. OBJECTIVES: Analysis of treatment of male horses affected with SCC of the external genitalia and long-term results of treatment. METHODS: Seventy-seven cases of SCC were evaluated. Data recorded included treatment, outcome, post operative histopathology and retrospective tumour grading. RESULTS: Treatments included: cryosurgery, excision, partial phallectomy, partial phallectomy and sheath ablation, and en bloc penile and preputial resection with penile retroversion and removal of inguinal lymph nodes. The incidence of recurrence after partial phallectomy was 25.6% (10/39) and following incomplete removal was 17.9% (7/39). The incidence of recurrence after en bloc resection with retroversion was 12.5% (1/8). In horses with confirmed inguinal lymph node metastasis, the incidence of recurrence was 25.0% (1/4). Poorly differentiated SCCs were more likely to metastasise than well differentiated SCCs, and there was a greater chance that the treatment would be unsuccessful. The success of treatment, complete removal and in preventing recurrence of the tumour, of male horses with SCC of the external genitalia was 55.7%. CONCLUSIONS: Horses that receive only partial phallectomy for treatment for SCC of the external genitalia have a high incidence of recurrence in contrast to horses that receive an en bloc resection. Tumour grading of SCC can help predict prognosis and guide selection of treatment.


Subject(s)
Carcinoma, Squamous Cell/veterinary , Horse Diseases/surgery , Penile Neoplasms/veterinary , Amputation, Surgical/veterinary , Animals , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/surgery , Horse Diseases/mortality , Horse Diseases/pathology , Horses , Inguinal Canal/surgery , Lymph Node Excision/veterinary , Lymph Nodes/pathology , Lymphatic Metastasis , Male , Neoplasm Metastasis , Neoplasm Recurrence, Local/epidemiology , Neoplasm Recurrence, Local/mortality , Neoplasm Recurrence, Local/veterinary , Neoplasm Staging/veterinary , Penile Neoplasms/mortality , Penile Neoplasms/pathology , Penile Neoplasms/surgery , Penis/surgery , Prognosis , Retrospective Studies , Treatment Outcome
7.
Vet Res Commun ; 29(3): 247-61, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15736857

ABSTRACT

The aminoglycoside gentamicin is often used in equine practice. Despite its clinical use, concerns remain regarding the potential toxic side-effects, such as nephrotoxicity, in equine patients, particularly after repeated dosing. The aim of the study was to investigate first in vitro the mechanisms contributing to the renal toxicity of gentamicin and to identify sensitive biomarkers indicating proximal tubule damage. To this end, the kidney-derived cell lines LLC-PKI and MDCK were treated with gentamicin at different concentrations. Toxicity was assessed by measuring the release of gamma-glutamyl transferase (GGT), and the production of reactive oxygen species (ROS). Cell viability was measured using Alamar blue (AB) and Neutral red (NR) cytotoxicity assays. Gentamicin exerted a dose-dependent toxicity. Primarily, loss of brush border membrane integrity, indicated by GGT leakage, and an increased ROS production were observed. As GGT was found to be a sensitive marker for gentamicin-induced renal cell injury, in the subsequent in vivo experiments, in which ponies were given gentamicin (3.0 mg/kg bw three times daily and 4.5 mg/kg bw twice daily) for five consecutive days, plasma levels and the urinary excretion of GGT and creatinine were measured and the GGT:creatinine ratio was calculated. Elevated GGT levels in urine following gentamicin therapy were observed, but this enzyme leakage was transient and returned to baseline values after cessation of therapy. It could thus be concluded that even a conservative dose regimen of gentamicin did not result in significant renal toxicity in healthy ponies.


Subject(s)
Anti-Bacterial Agents/toxicity , Gentamicins/toxicity , Kidney Tubules, Distal/drug effects , Kidney Tubules, Proximal/drug effects , Animals , Anti-Bacterial Agents/pharmacokinetics , Biomarkers/metabolism , Cell Survival/drug effects , Creatinine/metabolism , Dogs , Dose-Response Relationship, Drug , Fluorescence Polarization Immunoassay/veterinary , Gentamicins/pharmacokinetics , Horses , Kidney Tubules, Distal/enzymology , Kidney Tubules, Distal/pathology , Kidney Tubules, Proximal/enzymology , Kidney Tubules, Proximal/pathology , LLC-PK1 Cells , Male , Neutral Red , Oxazines , Reactive Oxygen Species/metabolism , Swine , Xanthenes , gamma-Glutamyltransferase/metabolism
8.
Vet Res Commun ; 29(2): 141-7, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15730138

ABSTRACT

The aminoglycoside antibiotic gentamicin is commonly used in equine medicine for the prevention and treatment of Gram-negative and staphylococcal bacteria in surgically treated colic patients. The pharmacokinetics of gentamicin in these patients might be altered by the disease status, and/or under the influence of fluid therapy. The purpose of this study was to investigate the effect of intravenous fluid treatment on gentamicin kinetics in colic patients. Colic patients subjected to laparotomy were given fluid infusions according to clinical status. Following gentamicin administration, blood samples were taken for gentamicin analysis at different time points, and the main pharmacokinetic parameters including Vc, Vss, t(1/2) and MRT were calculated. Horses undergoing fluid therapy showed a significantly different t(1/2), clearance and MRT as compared to non-infused patients. However, taking into account the clinical status of the patients receiving fluid support, the data suggest that endotoxaemia, rather than fluid therapy, influence gentamicin pharmacokinetics following laparotomy.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Colic/veterinary , Fluid Therapy/veterinary , Gentamicins/pharmacokinetics , Horse Diseases/therapy , Animals , Colic/drug therapy , Combined Modality Therapy/veterinary , Horse Diseases/metabolism , Horses , Time Factors
9.
Cancer Immunol Immunother ; 52(3): 179-84, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12649747

ABSTRACT

Local interleukin-2 (IL-2) is effective in a number of experimental animal models and in veterinary and human cancer patients without discomforting side effects. The primary goal of this study was to compare the therapeutic effects and side effects of the local intratumoral administration of five or ten low doses of IL-2 with those of a combination of cisplatin and a single high dose of IL-2 in the treatment of equine sarcoids. The therapeutic effect (complete and partial regression) of local cisplatin together with a single high dose of IL-2 was significantly better than the combined effect of low doses of local IL-2 administered daily over 5 or 10 days (80% and 43%, respectively; P=0.02). Cisplatin/IL-2 and low doses of IL-2 induced 53% and 14% complete regressions, respectively ( P=0.02). Histological changes after cisplatin/IL-2 treatment were far more pronounced than after IL-2 only treatment and in several cases showed an enormous eosinophilic infiltrate.


Subject(s)
Antineoplastic Agents/pharmacology , Cisplatin/pharmacology , Horse Diseases/therapy , Interleukin-2/pharmacology , Neoplasms/therapy , Neoplasms/veterinary , Skin Neoplasms/veterinary , Animals , Antineoplastic Combined Chemotherapy Protocols , Eosinophils/metabolism , Equidae , Female , Horse Diseases/pathology , Horses , Male , Neoplasm Recurrence, Local/prevention & control , Neoplasm Recurrence, Local/veterinary , Skin Neoplasms/pathology , Skin Neoplasms/therapy , Time Factors
10.
Equine Vet J ; 34(5): 516-22, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12358057

ABSTRACT

Equine acute abdominal disease is often associated with shock. Important aspects in the onset of this complication include hypovolaemia, the translocation of endotoxins from the gut and the subsequent activation of the cytokine network. The clinical efficacy of high volume continuous venovenous haemofiltration (HV-CVVH) and the clearance of cytokines were therefore investigated in an equine endotoxaemic model. Ten male Shetland ponies received a slow infusion of LPS (2 microg/kg bwt) under general anaesthesia. The treatment group (n = 5) received HV-CVVH (2 ml/kg bwt/min) using a 75 kD polymethylmethacrylate (PMMA filter). Haemodynamic, blood variable and cytokine (TNF, IL-1 and IL-6) measurements were performed every 30 min for a 6 h period. The ponies showed a typical reaction in mean pulmonary arterial pressure, blood chemical and haematological markers after LPS challenge. No significant differences were found between the treatment group and the control group. Only a slight increase in cardiac index and no marked decrease in mean arterial pressure were seen. A clear cytokine response was found in all ponies, though substantially different in magnitude between individuals. The clearance of cytokines from the blood increased in time, but did not lead to significant decrease in serum levels. In this study, HV-CVVH with a PMMA filter did not prove to have a significant beneficial effect on the course of experimental endotoxaemia in horses. However, in a more severe model, better efficacy might be obtained. Testing additional filters might lead to a more suitable therapy for horses.


Subject(s)
Cytokines/blood , Hemofiltration/veterinary , Horse Diseases/therapy , Shock, Septic/veterinary , Animals , Disease Models, Animal , Hemodynamics , Hemofiltration/methods , Horse Diseases/blood , Horse Diseases/physiopathology , Horses , Lipopolysaccharides/toxicity , Male , Shock, Septic/blood , Shock, Septic/physiopathology , Shock, Septic/therapy , Time Factors , Treatment Outcome
11.
Tijdschr Diergeneeskd ; 127(11): 350-4, 2002 Jun 01.
Article in Dutch | MEDLINE | ID: mdl-12073779

ABSTRACT

At the Department of Equine Sciences at Utrecht University a study was performed on the treatment of sarcoids with the cytostatic drug cisplatin. Fourteen horses with 23 sarcoids were treated in the period 2000-2001. Complete regression was seen in 78% of the tumours. No systemic side-effects were encountered. Although treatment was easy to perform, the ALARA (As Low As Reasonably Achievable) principle should be followed when using cytostatics.


Subject(s)
Antineoplastic Agents/therapeutic use , Cisplatin/therapeutic use , Horse Diseases/drug therapy , Skin Neoplasms/veterinary , Animals , Emulsions , Female , Horse Diseases/pathology , Horses , Male , Neoplasm Recurrence, Local/prevention & control , Neoplasm Recurrence, Local/veterinary , Prognosis , Skin Neoplasms/drug therapy , Skin Neoplasms/pathology , Treatment Outcome
12.
J Vet Med A Physiol Pathol Clin Med ; 48(9): 545-52, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11765811

ABSTRACT

Thrombophlebitis is a well-known complication of the use of long-term in-dwelling catheters. In humans, catheter material has been shown to strongly influence the occurrence of thrombophlebitis. In the horse, the influence of catheter material has been studied in healthy experimental animals, but information on the relative importance of this factor is lacking. To investigate which factors have most impact on the frequency of jugular vein thrombosis in post-surgical colic horses, a clinical study was performed on 38 animals. Horses were randomly divided into two groups. In one group a polytetrafluoroethylene catheter was used, in the other a polyurethane catheter. Both groups were clinically monitored and screened for signs of thrombophlebitis. Seven out of 38 horses developed thrombophlebitis. The type of catheter material used had no influence on thrombophlebitis development. Dwell time was significantly longer in horses that developed thrombophlebitis compared with those that did not. There was no relationship between the occurrence of thrombophlebitis and underlying disease or surgical treatment, suggesting that the general state of debilitation these horses experienced was the most important determinant for the development of thrombophlebiris. This was further stressed by the fact that seven horses developed thrombophlebitis of the contralateral vein that had been used for the induction of anaesthesia (this incidence is much higher than in horses anaesthetized for elective surgery). It is concluded that the state of debilitation is the most important determining factor for the occurrence of thrombophlebitis after the use of long-term in-dwelling intravenous catheters. This makes a substantial reduction of the incidence of thrombophlebitis difficult, but some progress can be made by consequently restricting dwell time.


Subject(s)
Catheters, Indwelling/veterinary , Colic/veterinary , Horse Diseases/etiology , Thrombophlebitis/veterinary , Animals , Catheters, Indwelling/adverse effects , Colic/surgery , Horse Diseases/epidemiology , Horse Diseases/surgery , Horses , Incidence , Polytetrafluoroethylene , Polyurethanes , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Postoperative Complications/veterinary , Risk Factors , Thrombophlebitis/epidemiology , Thrombophlebitis/etiology , Time Factors
13.
Hepatogastroenterology ; 46 Suppl 1: 1280-6, 1999 May.
Article in English | MEDLINE | ID: mdl-10429975

ABSTRACT

Interleukin-2 (IL-2) is a powerful drug for treating cancer. However, it is only powerful if it is properly applied. That is, IL-2 should be applied at the tumor site, because at the transition of normal and malignant tissue are the tumor infiltrating cells. These should be activated by IL-2. Local application implies that IL-2 can be used in relatively low doses. It is becoming clear that even a single injection of IL-2 can cure cancer. IL-2 can also enhance the therapeutic effects of irradiation and Cisplatin. Locally applied IL-2 therapy is virtually non-toxic.


Subject(s)
Interleukin-2/administration & dosage , Neoplasms/therapy , Animals , Carcinoma, Squamous Cell/therapy , Cattle , Cisplatin/therapeutic use , Combined Modality Therapy , Dose-Response Relationship, Drug , Eye Neoplasms/therapy , Humans , Injections, Intralesional , Lymphoma/therapy , Mammary Neoplasms, Experimental/therapy , Mast-Cell Sarcoma/therapy , Mice , Mice, Inbred DBA , Neoplasm Transplantation , Time Factors , Tumor Cells, Cultured , Urinary Bladder Neoplasms/therapy
14.
Vet Rec ; 141(7): 172-4, 1997 Aug 16.
Article in English | MEDLINE | ID: mdl-9290196
15.
J Vet Pharmacol Ther ; 19(6): 439-44, 1996 Dec.
Article in English | MEDLINE | ID: mdl-8971672

ABSTRACT

The distribution of penicillins into a tissue chamber implanted subcutaneously in ponies was studied. Ampicillin sodium (equivalent to 15 mg/kg ampicillin) was administered intravenously. Pivampicillin, a prodrug of ampicillin, was administered by nasogastric tube to fed ponies at a dose of 19.9 mg/kg (equivalent to 15 mg/kg ampicillin). Procaine penicillin G was administered intramuscularly at a dose of 12 mg/kg (equivalent to 12000 IU/kg). Six ponies were used for each medication. Antibiotic concentrations in plasma and tissue chamber fluid (TCF) were measured for 24 h after administration. Mean peak concentrations of ampicillin in TCF were 7.3 micrograms/mL, reached at 1.7 h, and 1.3 micrograms/mL, reached at 2.7 h, after administration of ampicillin sodium and pivampicillin respectively. The mean peak concentration of penicillin G of 0.3 microgram/mL was reached 12.3 h after administration of procaine penicillin G. Concentrations in TCF remained above the minimum inhibitory concentration of Streptococcus zooepidemicus for the proposed dosing intervals of 8, 12 and 24 h for ampicillin sodium, pivampicillin and procaine penicillin G respectively.


Subject(s)
Ampicillin/metabolism , Penicillin G/metabolism , Penicillins/metabolism , Pivampicillin/metabolism , Ampicillin/administration & dosage , Ampicillin/blood , Ampicillin/pharmacokinetics , Animals , Biological Availability , Chromatography, High Pressure Liquid/veterinary , Extracellular Space/metabolism , Horses , Injections, Intravenous/veterinary , Microbial Sensitivity Tests , Penicillin G/administration & dosage , Penicillin G/blood , Penicillin G/pharmacokinetics , Penicillins/administration & dosage , Penicillins/blood , Penicillins/pharmacokinetics , Pivampicillin/administration & dosage , Pivampicillin/blood , Pivampicillin/pharmacokinetics , Polymers , Prostheses and Implants , Skin/metabolism , Spectrophotometry, Ultraviolet
16.
J Vet Pharmacol Ther ; 19(6): 445-53, 1996 Dec.
Article in English | MEDLINE | ID: mdl-8971673

ABSTRACT

Tissue chambers, implanted subcutaneously in ponies, were inoculated with Streptococcus zooepidemicus. The animals received either no antibiotics or one of the following treatments: pivampicillin per os (19.9 mg/kg, equivalent to 15 mg/kg ampicillin, every 12 h) for 7 or 21 days (7 and 5 ponies, respectively), procaine penicillin G intramuscularly (12 mg/kg = 12,000 IU/kg, every 24 h) for 7 days (7 ponies), or ampicillin sodium intravenously (equivalent to 15 mg/ kg ampicillin, every 8 h) for 1 day (5 ponies). Only intravenous administration was started before infection (prophylactically), the other treatments were started 20 h after infection (curatively). A total of 7 ponies received no antibiotics. In untreated controls, the infection led to abscessation of the tissue chamber in 4 to 10 days. Curative treatment with either pivampicillin or procaine penicillin G for 7 days resulted in a reduction of viable bacteria in the tissue chamber but did not eliminate the infection, resulting in abscessation in 5 to 14 days. However, administration of pivampicillin for 21 days eliminated the streptococci in five out of five ponies and prophylactic administration of ampicillin was successful in three out of five ponies.


Subject(s)
Ampicillin/therapeutic use , Penicillin G/therapeutic use , Penicillins/therapeutic use , Pivampicillin/therapeutic use , Soft Tissue Infections/drug therapy , Ampicillin/administration & dosage , Ampicillin/blood , Ampicillin/pharmacology , Animals , Chromatography, High Pressure Liquid/veterinary , Horse Diseases/drug therapy , Horses , Injections, Intravenous/veterinary , Leukocyte Count , Microbial Sensitivity Tests , Neck , Penicillin G/administration & dosage , Penicillin G/blood , Penicillin G/pharmacology , Penicillins/administration & dosage , Penicillins/blood , Penicillins/pharmacology , Pivampicillin/administration & dosage , Pivampicillin/blood , Pivampicillin/pharmacology , Polymers , Prostheses and Implants , Soft Tissue Infections/veterinary , Streptococcal Infections/drug therapy
17.
Int J Cancer ; 66(3): 400-3, 1996 May 03.
Article in English | MEDLINE | ID: mdl-8621264

ABSTRACT

In this report we present studies on optimal regimes for regional IL-2 therapy, focused on dose, schedule and site of injection. Original data obtained in 2 murine tumour models show that all 3 factors are of importance. Anti-tumour responses were most effective when IL-2 was administered regionally 5 to 10 times, at doses ranging from 7,000 to 33,000 IU/day every day or every other day. This resulted in cure rates of more than 40% in mice bearing ascitic tumour that had also disseminated to liver and lungs. The importance of these data is discussed in the light of previous results of our group. These results illustrate that the doses and schedules used in this study are not effective exclusively in these 2 tumour models but may have a more general applicability.


Subject(s)
Interleukin-2/therapeutic use , Lymphoma, Non-Hodgkin/therapy , Mast-Cell Sarcoma/therapy , Animals , Cattle , Dose-Response Relationship, Drug , Drug Administration Schedule , Female , Interleukin-2/administration & dosage , Liver Neoplasms/secondary , Liver Neoplasms/therapy , Lung Neoplasms/secondary , Lung Neoplasms/therapy , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C3H , Mice, Inbred C57BL , Mice, Inbred DBA , Rats , Rats, Inbred ACI , Time Factors
18.
Vet Rec ; 138(11): 253-6, 1996 Mar 16.
Article in English | MEDLINE | ID: mdl-8734507

ABSTRACT

To evaluate the side effects of oral pivampicillin and trimethoprim/ sulphadiazine, 200 horses receiving these antimicrobial agents were studied. The horses received either trimethoprim/ sulphadiazine (30 mg/kg twice daily) or pivampicillin (25 mg/kg twice daily) for three or more days. No adverse effects other than loose faeces and diarrhoea were detected. The risk of diarrhoea was significantly less after the oral administration of pivampicillin (3 per cent) than after trimethoprim/ sulphadiazine (7 per cent). Horses whose appetite was reduced appeared to be predisposed to develop diarrhoea after the administration of either oral antimicrobial agent.


Subject(s)
Anti-Infective Agents/adverse effects , Diarrhea/veterinary , Horse Diseases/chemically induced , Pivampicillin/adverse effects , Sulfadiazine/adverse effects , Trimethoprim/adverse effects , Administration, Oral , Animals , Anti-Infective Agents/administration & dosage , Diarrhea/chemically induced , Diarrhea/epidemiology , Drug Combinations , Female , Horse Diseases/epidemiology , Horses , Incidence , Male , Pivampicillin/administration & dosage , Sulfadiazine/administration & dosage , Trimethoprim/administration & dosage
19.
Vet Pathol ; 33(1): 92-5, 1996 Jan.
Article in English | MEDLINE | ID: mdl-8826014

ABSTRACT

Three cases of carcinoid tumor in horses are described. The tumors originated from the maxillary sinuses and the retrobulbar region and caused exophthalmos. Histologically, they had a characteristic endocrine pattern and were argyrophilic with the Grimelius stain. All tumors contained reactivity for neuron-specific enolase and synaptophysin. Two of three tumors were reactive for both bovine and porcine chromogranin A. These immunohistochemical results confirm the neuroendocrine nature of these tumors. Neuroendocrine cells could not be detected in the nasal mucosa and maxillary sinuses of a normal horse; therefore, the origin of these carcinoid tumors remains obscure.


Subject(s)
Carcinoid Tumor/veterinary , Horse Diseases/diagnosis , Maxillary Sinus Neoplasms/veterinary , Nose Neoplasms/veterinary , Animals , Carcinoid Tumor/chemistry , Carcinoid Tumor/diagnosis , Chromogranin A , Chromogranins/analysis , Chromogranins/metabolism , Horse Diseases/metabolism , Horse Diseases/pathology , Horses , Immunohistochemistry , Maxillary Sinus Neoplasms/chemistry , Maxillary Sinus Neoplasms/diagnosis , Nose Neoplasms/chemistry , Nose Neoplasms/diagnosis , Phosphopyruvate Hydratase/analysis , Phosphopyruvate Hydratase/metabolism , Synaptophysin/analysis , Synaptophysin/metabolism , Tomography, X-Ray Computed
20.
Am J Vet Res ; 56(11): 1440-4, 1995 Nov.
Article in English | MEDLINE | ID: mdl-8585653

ABSTRACT

In Zimbabwe, ocular squamous cell carcinoma (OSCC) was frequently observed in 5 breeding herds of Simmental cattle, a Bos taurus breed originating from Switzerland. In these herds, initial signs of OSCC were already noticeable in cattle about 3 years old. Gradually, OSCC prevalence increased, and 36 to 53% of cattle over 7 years old had 1 or more tumors. More tumors developed in Simmental cattle with periorbital white skin than in cattle with periorbital pigmented skin. Other breeds of cattle (eg, Friesian) also are partly white-faced and live in Zimbabwe in a comparable environment; yet, OSCC prevalence was lower in those breeds.


Subject(s)
Carcinoma, Squamous Cell/veterinary , Cattle Diseases , Eye Neoplasms/veterinary , Aging , Animals , Carcinoma, Squamous Cell/epidemiology , Cattle , Eye Neoplasms/epidemiology , Female , Male , Odds Ratio , Species Specificity , Zimbabwe/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...